Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation

Blood (2020) 135 (6): 441–448.

https://doi.org/10.1182/blood.2019002320

Published: 2020

Includes: Supplemental data

Journal Articles

The Multidrug Transporter MRP4/ABCC4 Involved in the Leukemia Clinical Course Specifies the Novel PEL Human Blood Group System

Blood (2019) 134 (Supplement_1): 715.

https://doi.org/10.1182/blood-2019-124082

Published: 2019

Journal Articles

Viral, immunologic, and clinical features of primary effusion lymphoma

Kathryn Lurain, Mark N. Polizzotto, Karen Aleman, Manisha Bhutani, Kathleen M. Wyvill, Priscila H. Gonçalves, Ramya Ramaswami, Vickie Ann Marshall, Wendell Miley, Seth M. Steinberg, Richard F. Little, Wyndham Wilson, Armando C. Filie, Stefania Pittaluga, Elaine S. Jaffe, Denise Whitby, Robert Yarchoan, Thomas S. Uldrick

Blood (2019) 133 (16): 1753–1761.

https://doi.org/10.1182/blood-2019-01-893339

Published: 2019

Journal Articles

Biology and management of primary effusion lymphoma

Kazuyuki Shimada, Fumihiko Hayakawa, Hitoshi Kiyoi

Blood (2018) 132 (18): 1879–1888.

https://doi.org/10.1182/blood-2018-03-791426

Published: 2018

Journal Articles

CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma

Ajinkya Patil, Mark Manzano, Eva Gottwein

Blood (2018) 132 (6): 577–586.

https://doi.org/10.1182/blood-2018-01-828418

Published: 2018

Includes: Supplemental data

Journal Articles

Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma

Lu Dai, Jimena Trillo-Tinoco, Yueyu Cao, Karlie Bonstaff, Lisa Doyle, Luis Del Valle, Denise Whitby, Chris Parsons, Krzysztof Reiss, Jovanny Zabaleta, Zhiqiang Qin

Blood (2015) 126 (26): 2821–2831.

https://doi.org/10.1182/blood-2015-07-658823

Published: 2015

Includes: Supplemental data

Journal Articles

Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies

Utthara Nayar, Pin Lu, Rebecca L. Goldstein, Jelena Vider, Gianna Ballon, Anna Rodina, Tony Taldone, Hediye Erdjument-Bromage, Max Chomet, Ronald Blasberg, Ari Melnick, Leandro Cerchietti, Gabriela Chiosis, Y. Lynn Wang, Ethel Cesarman

Blood (2013) 122 (16): 2837–2847.

https://doi.org/10.1182/blood-2013-01-479972

Published: 2013

Includes: Supplemental data

Journal Articles

CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma

Shruti Bhatt, Brittany M. Ashlock, Yasodha Natkunam, Victoria Sujoy, Jennifer Rose Chapman, Juan Carlos Ramos, Enrique A. Mesri, Izidore S. Lossos

Blood (2013) 122 (7): 1233–1242.

https://doi.org/10.1182/blood-2013-01-481713

Published: 2013

Includes: Supplemental data

Journal Articles

T-cell immunity to Kaposi sarcoma–associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4 + T cells

Shereen Sabbah, Ya Jankey Jagne, Jianmin Zuo, Thushan de Silva, Mohammad M. Ahasan, Christian Brander, Sarah Rowland-Jones, Katie L. Flanagan, Andrew D. Hislop

Blood (2012) 119 (9): 2083–2092.

https://doi.org/10.1182/blood-2011-07-366476

Published: 2012

Journal Articles

Synergistic Preclinical Activity of Bortezomib with Suberoylanilide Hydroxamic Acid (SAHA) in Primary Effusion Lymphoma (PEL)

Shruti Bhatt, Brittany Ashlock, Ngoc Toomey, Enrique Mesri, PhD, Juan Carlos Ramos, MD, Izidore S Lossos, MD

Blood (2011) 118 (21): 1650.

https://doi.org/10.1182/blood.V118.21.1650.1650

Published: 2011

Journal Articles

Preclinical Activity of Brentuximab Vedotin (SGN-35) in Primary Effusion Lymphoma (PEL),

Shruti Bhatt, Brittany Ashlock, Yaso Natkunam, MD, PhD, Juan Carlos Ramos, MD, Enrique Mesri, PhD, Izidore S Lossos, MD

Blood (2011) 118 (21): 3728.

https://doi.org/10.1182/blood.V118.21.3728.3728

Published: 2011

Journal Articles

Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines

Debasmita Roy, Sang-Hoon Sin, Blossom Damania, Dirk P. Dittmer

Blood (2011) 118 (7): e32–e39.

https://doi.org/10.1182/blood-2010-12-323659

Published: 2011

Includes: Supplemental data

Journal Articles

Multicenter Analysis of 150 Very Elderly Non-Hodgkin's Lymphoma (NHL) Patients: Impact of Comorbidities and Response to Initial Therapy on Survival

Andrew M Evens, DO, MSc, Chadi Nabhan, MD, FACP, Irene Helenowski, PhD, Annette Larsen, B.A., R.N., Erika E. Ramsdale, MD, Reem Karmali, MD, Josephine L. Feliciano, MD, Benjamin Parsons, MD, June M McKoy, MD, JD, MPH, MBA, Stephanie A. Gregory, MD, Sonali M Smith, MD

Blood (2010) 116 (21): 3124.

https://doi.org/10.1182/blood.V116.21.3124.3124

Published: 2010

Journal Articles

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas

Aadra P. Bhatt, Prasanna M. Bhende, Sang-Hoon Sin, Debasmita Roy, Dirk P. Dittmer, Blossom Damania

Blood (2010) 115 (22): 4455–4463.

https://doi.org/10.1182/blood-2009-10-251082

Published: 2010

Includes: Supplemental data

Journal Articles

It is Different the Survival of Primary Extranodal Non Hodgkin Lymphoma?.

Pilar Giraldo, MD, Esther Franco-Garcia, Ramiro Alvarez, Gloria Garcia-Carpintero, Carmen Martos

Blood (2009) 114 (22): 5028.

https://doi.org/10.1182/blood.V114.22.5028.5028

Published: 2009

Journal Articles

Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma

Andrea J. O'Hara, Ling Wang, Bruce J. Dezube, William J. Harrington, Jr, Blossom Damania, Dirk P. Dittmer

Blood (2009) 113 (23): 5938–5941.

https://doi.org/10.1182/blood-2008-09-179168

Published: 2009

Includes: Supplemental data

Journal Articles

Antineoplastic activity of lentiviral vectors expressing interferon-α in a preclinical model of primary effusion lymphoma

Maria Luisa Calabrò, Paola Gasperini, Iole Maria Di Gangi, Stefano Indraccolo, Massimo Barbierato, Alberto Amadori, Luigi Chieco-Bianchi

Blood (2009) 113 (19): 4525–4533.

https://doi.org/10.1182/blood-2008-09-180307

Published: 2009

Includes: Supplemental data

Journal Articles

HIV-associated lymphomas and gamma-herpesviruses

Antonino Carbone, Ethel Cesarman, Michele Spina, Annunziata Gloghini, Thomas F. Schulz

Blood (2009) 113 (6): 1213–1224.

https://doi.org/10.1182/blood-2008-09-180315

Published: 2009

Journal Articles

Generation of vFLIP Transgenic Mice: A Model to Study KSHV-Associated Lymphomagenesis

Gianna Ballon, MD, Amy Chadburn, MD, Rocio Perez, MA, Yi-Fang Liu, MD, Yoshiteru Sasaki, MD, PhD, Ethel Cesarman, MD, PhD

Blood (2008) 112 (11): 81.

https://doi.org/10.1182/blood.V112.11.81.81

Published: 2008

Journal Articles

KSHV LANA inhibits TGF-β signaling through epigenetic silencing of the TGF-β type II receptor

Daniel L. Di Bartolo, Mark Cannon, Yi-Fang Liu, Rolf Renne, Amy Chadburn, Chris Boshoff, Ethel Cesarman

Blood (2008) 111 (9): 4731–4740.

https://doi.org/10.1182/blood-2007-09-110544

Published: 2008

NARROW

Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation

The Multidrug Transporter MRP4/ABCC4 Involved in the Leukemia Clinical Course Specifies the Novel PEL Human Blood Group System

Viral, immunologic, and clinical features of primary effusion lymphoma

Biology and management of primary effusion lymphoma

CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma

Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma

Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies

CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma

T-cell immunity to Kaposi sarcoma–associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4 + T cells

Synergistic Preclinical Activity of Bortezomib with Suberoylanilide Hydroxamic Acid (SAHA) in Primary Effusion Lymphoma (PEL)

Preclinical Activity of Brentuximab Vedotin (SGN-35) in Primary Effusion Lymphoma (PEL),

Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines

Multicenter Analysis of 150 Very Elderly Non-Hodgkin's Lymphoma (NHL) Patients: Impact of Comorbidities and Response to Initial Therapy on Survival

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas

It is Different the Survival of Primary Extranodal Non Hodgkin Lymphoma?.

Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma

Antineoplastic activity of lentiviral vectors expressing interferon-α in a preclinical model of primary effusion lymphoma

HIV-associated lymphomas and gamma-herpesviruses

Generation of vFLIP Transgenic Mice: A Model to Study KSHV-Associated Lymphomagenesis

KSHV LANA inhibits TGF-β signaling through epigenetic silencing of the TGF-β type II receptor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only